Skip to main content
Caplight Logo









OnKure Therapeutics

OnKure Therapeutics

Public
Boulder, ColoradoBiotechhttps://www.onkuretherapeutics.com

OnKure Therapeutics is now publicly traded

The data on this page reflects OnKure Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Oct 4, 2024

Est. Valuation at Exit

$305.16M

Total Funding Raised

$181M

Company Overview

OnKure Therapeutics is a biopharmaceutical company dedicated to discovering and developing advanced precision medicines that target validated cancer drivers, addressing unmet needs in current therapies.

Sector

Biotech

AI Layer

Non-AI

Keywords

selective PI3Kα H1047R inhibitormutant-selective PI3Kα inhibitor programwild-type sparing cancer therapyprecision medicines for cancerstructure-based drug design platformorally bioavailable small molecule inhibitorprecision oncology drug discoverysolid tumor cancer therapyclinical-stage biopharmaceutical companytherapies for genetically-defined cancers

OnKure Therapeutics Comparables

Compare OnKure Therapeutics with similar companies based on industry and business-model similarity.

OnKure Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Eli Lilly and Company
54%
Vaderis Therapeutics
40%

OnKure Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementOct 4, 2024
Series CMar 31, 2023
Series BMar 3, 2021
Series AMay 2, 2018

OnKure Therapeutics Investors

Notable investors and investment history

OnKure Therapeutics investors
InvestorRounds
Perceptive AdvisorsSeries B, Private Placement, Series C
Deep Track CapitalPrivate Placement, Series C
Vestal Point CapitalPrivate Placement
Delian CapitalSeries A
Acorn BioventuresPrivate Placement, Series C, Series B
CitadelPrivate Placement, Series C, Series B
Samsara BioCapitalSeries B, Private Placement, Series C

OnKure Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OnKure Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersBoulder, Colorado
Employee Range41
Year Founded2011
Last FundingOct 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?